Research Topics
| M E PfistererSummaryAffiliation: University Hospital Country: Switzerland Publications
| Collaborators
|
Detail Information
Publications
Prevention of supraventricular tachyarrhythmias after open heart operation by low-dose sotalol: a prospective, double-blind, randomized, placebo-controlled studyM E Pfisterer
Department of Internal Medicine, and Clinic for Cardiothoracic Surgery, University Hospital, Basel, Switzerland
Ann Thorac Surg 64:1113-9. 1997..The aim of this prospective, double-blind, placebo-controlled trial was to assess the preventive effect and safety of low-dose sotalol after heart operation...
Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stentsMatthias Pfisterer
Department of Cardiology, University Hospital, Basel, Switzerland
J Am Coll Cardiol 48:2584-91. 2006..We sought to define the incidence of late clinical events and late stent thrombosis in patients treated with drug-eluting (DES) versus bare-metal stents (BMS) after the discontinuation of clopidogrel as well as their timing and outcome...
Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: four-year follow-up of the randomized Trial of Invasive versus Medical therapy in Elderly patients (TIME)Matthias Pfisterer
Department of Cardiology, University Hospital, Basel, Switzerland
Circulation 110:1213-8. 2004..There are no prospective trial data on long-term outcomes in 80-year-old patients with chronic angina with regard to antiischemic therapy...
Long-term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKETMatthias Pfisterer
Department of Cardiology, University Hospital Basel, Petersgraben, Basel, Switzerland
Eur Heart J 30:16-24. 2009..To assess the long-term benefit-risk ratio of drug-eluting (DES) vs. bare-metal stents (BMS) relative to stent size...
Improvements in physical and mental domains of quality of life by anti-ischaemic drug and revascularisation treatment in elderly men and women with chronic anginaM A Buser
Department of Cardiology, University Hospital, Basel, Switzerland
Heart 94:1413-8. 2008..It is not known, however, whether improvements relate only to physical or also to mental and social domains of QoL and whether women benefit in a similar way to men...
Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: study protocol and designMatthias Pfisterer
Department of Cardiology, University Hospital Basel, Basel, Switzerland
Am Heart J 155:609-14. 2008....
BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trialMatthias Pfisterer
Department of Cardiology, University Hospital Basel, CH 4031 Basel, Switzerland
JAMA 301:383-92. 2009..It is uncertain whether intensified heart failure therapy guided by N-terminal brain natriuretic peptide (BNP) is superior to symptom-guided therapy...
Right ventricular involvement in myocardial infarction and cardiogenic shockMatthias Pfisterer
Division of Cardiology, University Hospital, CH 4031, Basel, Switzerland
Lancet 362:392-4. 2003..If right ventricular shock is diagnosed, urgent reperfusion of the infarct related artery and appropriate circulatory support are required...
Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trialMatthias Pfisterer
Department of Cardiology, University Hospital, Petersgraben 4, CH 4031 Basel, Switzerland
JAMA 289:1117-23. 2003..The Trial of Invasive versus Medical therapy in Elderly patients (TIME) recently showed early benefits in quality of life from invasive therapy in patients aged 75 years or older, although with a certain excess in mortality...
Time dependence of left ventricular recovery after delayed recanalization of an occluded infarct-related coronary artery: findings of a pilot studyM E Pfisterer
Department of Internal Medicine, University Hospital, Basel, Switzerland
J Am Coll Cardiol 32:97-102. 1998..We sought to test the hypothesis that late recanalization of infarct-related coronary arteries (IRAs) improves long-term left ventricular (LV) function...
Long-term outcome of angioplasty for multivessel coronary disease: importance and price of complete revascularizationU C Kloeter
Division of Cardiology, Department of Internal Medicine, University Hospital, Basel, Switzerland
Int J Cardiol 79:197-205. 2001..CONCLUSION: MVD angioplasty with complete revascularization has a long-term event-free survival similar to that of SVD angioplasty but at the price of a higher rate of 6-month restenosis and repeat interventions...
Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trialT Burkard
Cardiology, University Hospital, Basel, Switzerland
J Intern Med 271:257-63. 2012..To investigate whether there is an increased risk of cardiac events with a combined therapy of clopidogrel and proton pump inhibitors (PPIs) after percutaneous coronary intervention (PCI)...
Primary PCI in STEMI--dilemmas and controversies: multivessel disease in STEMI patients. Complete versus Culprit Vessel revascularization in acute ST--elevation myocardial infarctionR V Jeger
Department of Cardiology, University Hospital Basel, Basel, Switzerland
Minerva Cardioangiol 59:225-33. 2011..It should be considered whether current guidelines should be changed to account for these considerations, and other adequately powered randomized controlled trials should be performed to endorse current knowledge...
Management of elderly patients with congestive heart failure--design of the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF)Hans Peter Brunner-La Rocca
Division of Cardiology, University Hospital Basel, Basel, Switzerland
Am Heart J 151:949-55. 2006..It will provide unique information comparing two treatment strategies in two age groups irrespective of ejection fraction regarding prognosis, quality of life, as well as resource utilization and costs...
Elevated troponin levels in absence of coronary artery disease after supraventricular tachycardiaM J Zellweger
Cardiology Department, University Hospital, Basel, Switzerland
Swiss Med Wkly 133:439-41. 2003..Four patients with elevated troponin levels after supraventricular tachycardia without evidence of coronary artery disease and very low risk scores for acute coronary syndrome are described and discussed...
Cost-effectiveness of invasive versus medical management of elderly patients with chronic symptomatic coronary artery disease. Findings of the randomized trial of invasive versus medical therapy in elderly patients with chronic angina (TIME)Jacques Claude
Division of Cardiology, University Hospital, CH-4031 Basel, Switzerland
Eur Heart J 25:2195-203. 2004..Costs should not be an argument against invasive management of elderly patients with chronic angina...
Risks and benefits of optimised medical and revascularisation therapy in elderly patients with angina--on-treatment analysis of the TIME trialChristoph Kaiser
Department of Cardiology, University Hospitals Basel, Petersgraben 4, 4031 Basel, Switzerland
Eur Heart J 25:1036-42. 2004....
Comparison of presentation, perception, and six-month outcome between women and men > or =75 years of age with angina pectorisGabriela M Kuster
University Hospital, Basel, Switzerland
Am J Cardiol 91:436-9. 2003
Stunning and left ventricular function--how long is the ventricle knocked out? Left ventricular function correlated with ischemic burden and recovery time after stressB A Kaufmann
Department of Cardiology, University Hospital, Basel, Switzerland
Int J Cardiol 112:223-8. 2006..Little is known about the relation between severity of ischemia and duration of myocardial stunning. The aim of this study was therefore to characterize the impact of ischemia on myocardial stunning and on its duration...
Drug treatment of chronic heart failure in the elderlyGregor Leibundgut
Cardiology, University Hospital Basel, Basel, Switzerland
Drugs Aging 24:991-1006. 2007....
Targeted stent use in clinical practice based on evidence from the Basel Stent Cost Effectiveness Trial (BASKET)Hans Peter Brunner La Rocca
Division of Cardiology, University Hospital Basel, Switzerland
Eur Heart J 28:719-25. 2007..It is unknown which patients benefit most from drug-eluting stents (DES) against bare-metal stents (BMS) in a long-term clinical outcome...
Early and late increased bleeding rates after angioplasty and stenting due to combined antiplatelet and anticoagulanttherapyChristophe Hälg
Department of Cardiology, University Hospital Basel, Basel, Switzerland
EuroIntervention 5:425-31. 2009..To assess major bleeding complications in patients after coronary stenting who are on dual antiplatelet drugs with or without oral anticoagulants...
Anemia as independent predictor of major events in elderly patients with chronic anginaStefano Muzzarelli
Division of Cardiology, University Hospital, Basel, Switzerland
Am Heart J 152:991-6. 2006..3 g/dL by 23% (adjusted risk ratio 1.23, P = .01). CONCLUSION: Anemia proved to be an independent predictor of death and major clinical adverse events among elderly patients with stable symptomatic CAD...
Drug-eluting versus bare-metal stents in large coronary arteriesChristoph Kaiser
Department of Cardiology, University Hospital, CH 4031 Basel, Switzerland
N Engl J Med 363:2310-9. 2010..We sought to confirm this observation and to assess whether this increase in risk was also seen with second-generation drug-eluting stents...
Cost-effectiveness of drug-eluting stents in patients at high or low risk of major cardiac events in the Basel Stent KostenEffektivitäts Trial (BASKET): an 18-month analysisHans Peter Brunner La Rocca
Department of Cardiology, University Hospital, Basel, Switzerland
Lancet 370:1552-9. 2007..Our aim was to determine whether drug-eluting stents are good value for money in long-term, everyday practice...
Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trialPaul Erne
Division of Cardiology, Kantonsspital Luzern, Luzern, Switzerland
JAMA 297:1985-91. 2007..The effect of a percutaneous coronary intervention (PCI) on the long-term prognosis of patients with silent ischemia after a myocardial infarction (MI) is not known...
Silent coronary artery disease in patients with diabetes mellitusM J Zellweger
Department of Cardiology, University Hospital Basel, Switzerland
Swiss Med Wkly 131:427-32. 2001..Asymptomatic high-risk diabetic patients therefore might benefit from routine screening for silent ischaemia and risk stratification; furthermore, silent ischaemia has to be treated accordingly...
Coronary artery disease and outcome in acute congestive heart failureL Purek
Department of Internal Medicine, University of Basel, University Hospital, Basel, Switzerland
Heart 92:598-602. 2006..Whether, for example, less restrictive use of revascularisation procedures in this elderly HF population can improve the outcome for patients with CAD warrants further study...
Limited diagnostic yield of non-invasive coronary angiography by 16-slice multi-detector spiral computed tomography in routine patients referred for evaluation of coronary artery diseaseChristoph Kaiser
Division of Cardiology, University Hospital, CH 4031 Basel, Switzerland
Eur Heart J 26:1987-92. 2005..As no detailed comparative evaluation in consecutive patients referred for evaluation of CAD has been reported, this prospective study evaluating 2384 coronary segments in 149 consecutive patients was performed...
Bedside quantification of atherosclerosis severity for cardiovascular risk stratification: a prospective cohort studyPatrick R Hunziker
Medical Intensive Care Unit, University Hospital, Basel, Switzerland
J Am Coll Cardiol 39:702-9. 2002..We sought to assess the ability of a new noninvasive method to quantify atherosclerosis severity and to examine its power to predict cardiovascular events...
Use of B-type natriuretic peptide in the evaluation and management of acute dyspneaChristian Mueller
Department of Internal Medicine, Medical Division A, University of Basel, University Hospital, Basel, Switzerland
N Engl J Med 350:647-54. 2004..B-type natriuretic peptide levels are higher in patients with congestive heart failure than in patients with dyspnea from other causes...
Troubleshooting for a stuck balloon-catheterPeter Matt
Division of Cardiothoracic Surgery, University Hospital Basel, Basel, Switzerland
Ann Thorac Surg 83:320. 2007
Predictors of early readmission or death in elderly patients with heart failureStefano Muzzarelli
Department of Cardiology, University Hospital Basel, Basel, Switzerland
Am Heart J 160:308-14. 2010..Prior studies were focused on younger and less well-characterized patients. We aimed to identify predictors of early hospital readmission and death in elderly patients with HF...
Comparative outcome one year after formal cardiac rehabilitation: the effects of a randomized intervention to improve exercise adherenceInes Arrigo
Division of Cardiology, University Hospital, Basel, Switzerland
Eur J Cardiovasc Prev Rehabil 15:306-11. 2008..Methods to ensure sustained benefits of cardiac rehabilitation need to be explored. The aim was to assess the effect of a home-based intervention (INT) on exercise adherence and risk factors after cardiac rehabilitation...
Usefulness of B-type natriuretic peptide and C-reactive protein in predicting the presence or absence of left ventricular hypertrophy in patients with systemic hypertensionDavid Conen
Department of Cardiology, University Hospital Basel, Basel, Switzerland
Am J Cardiol 97:249-52. 2006..In conclusion, in hypertensive patients, echocardiographic LV hypertrophy can be excluded on the basis of a single blood sample for the determination of BNP and CRP...
Right atrial pacing impairs cardiac function during resynchronization therapy: acute effects of DDD pacing compared to VDD pacingAlain Bernheim
Division of Cardiology, University Hospital, Basel, Switzerland
J Am Coll Cardiol 45:1482-7. 2005..Thus, the VDD mode seems to be superior to the DDD mode in CRT patients...
Long-term performance of a simple algorithm for early discharge after ruling out acute coronary syndrome: a prospective multicenter trialBeat Andreas Schaer
University Hospital, Petersgraben 4, CH-4031 Basel, Switzerland
Chest 127:1364-70. 2005....
Cell targeting by a generic receptor-targeted polymer nanocontainer platformPavel Broz
Medical Intensive Care Unit, University Hospital Basel, Petersgraben 4, Basel CH 4031, Switzerland
J Control Release 102:475-88. 2005..Low nonspecific binding supported the "stealth" properties of the carrier while cytotoxicity was absent. This versatile carrier appears promising for diagnostic or therapeutic medical use...
Direct stenting with TAXUS stents seems to be as safe and effective as with predilatation. A post hoc analysis of TAXUS IISigmund Silber
Cardiology Practice and Hospital, Munich, Germany
Herz 29:171-80. 2004..While predilatation was recommended per protocol, direct stenting was not forbidden: thus, direct stenting was performed in 49 patients (TAXUS n = 23, control n = 26)...
Correlates of one-year survival inpatients with cardiogenic shock complicating acute myocardial infarction: angiographic findings from the SHOCK trialTimothy A Sanborn
Evanston Northwestern Healthcare, Evanston, Illinois 60201, USA
J Am Coll Cardiol 42:1373-9. 2003....
Heart rate variability and cardiac troponin I are incremental and independent predictors of one-year all-cause mortality after major noncardiac surgery in patients at risk of coronary artery diseaseMiodrag Filipovic
Department of Anesthesia, University of Basel Kantonsspital, Switzerland
J Am Coll Cardiol 42:1767-76. 2003....
The balance of risks and benefits of drug-eluting versus bare-metal stentsMatthias Pfisterer
J Am Coll Cardiol 51:972; author reply 972-3. 2008
Use of evidence-based medicine for acute coronary syndromes in the elderly and very elderly: insights from the Sibrafiban vs aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes trialsCheuk Kit Wong
Cardiology, Dunedin School of Medicine, Otago University, Dunedin, New Zealand
Am Heart J 154:313-21. 2007..Evidence-based medications (EBM) are underused in older patients despite potentially larger absolute benefits. Little is known about factors influencing prescribing in the elderly with acute coronary syndromes...
Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromesDarren K McGuire
Donald W Reynolds Cardiovascular Clinical Research Center at the University of Texas Southwestern Medical Center, Dallas, Tex, USA
Am Heart J 147:246-52. 2004..The relative effect of glucose-lowering strategies of "insulin provision" versus "insulin sensitization" among patients with CAD remains unclear...
Prognostic value of abnormal vasoreactivity of epicardial coronary arteries to sympathetic stimulation in patients with normal coronary angiogramsThomas H Schindler
Division of Cardiology, Medical Clinic III, University Hospital of the Albert Ludwig University, Freiburg, Germany
Arterioscler Thromb Vasc Biol 23:495-501. 2003..We aimed to evaluate prospectively whether patients with normal coronary angiogram but abnormal epicardial vasoreactivity to cold pressor test (CPT) are at increased risk for cardiovascular events...
[Increased rate of stent thrombosis with DES]Christoph Kaiser
Abteilung Kardiologie, Universitatsspital Basel, Schweiz
Herz 32:296-300. 2007..In addition, new second-generation DES with a decreased risk for late stent thrombosis have to be developed...
Coronary vasoregulation in patients with various risk factors in response to cold pressor testing: contrasting myocardial blood flow responses to short- and long-term vitamin C administrationThomas H Schindler
Division of Cardiology and Nuclear Medicine, Medical Clinic III, University Hospital of the Albert Ludwig University, Freiburg, Germany
J Am Coll Cardiol 42:814-22. 2003....
Raised cardiac troponinsPeter Ammann
BMJ 328:1028-9. 2004
Effects of anti-ischaemic drug therapy in silent myocardial ischaemia type I: the Swiss Interventional Study on Silent Ischaemia type I (SWISSI I): a randomized, controlled pilot studyPaul Erne
Kantonsspital, Luzern, Switzerland
Eur Heart J 28:2110-7. 2007..To determine the effect of anti-ischaemic drug therapy on long-term outcomes of asymptomatic patients without coronary artery disease (CAD) history but silent exercise ST-depression...
